ARCHIVES

Nexavar Improves PFS In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Pitot Supports Clearinghouse Modifications

January 20, 1978

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

Director’s Advisory Committee to Make Advice “Kosher”

March 7, 1997

ONS Scientific Program Grows

June 20, 1980

In Brief: M.D. Anderson Selects Raphael Pollock To Lead Surgery Div.; S.F. VA Picks Norton

September 12, 1997